These results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 help the concept of targeting ACKR3 as a novel strategy to modulate the opioid method, which could open new therapeutic avenues for opioid-linked Issues. These outcomes counsel that conolidine is https://shulamithd145lax2.ouyawiki.com/user